SportGait’s BKG Gait technology out-predicts leading gait and balance assessments by orders of magnitude.

WILMINGTON, N.C., February 23, 2023 (Newswire.com)
–
SportGait, the brain wellness and medical technology company, proudly announced today the publication of an article in the Journal of Concussion validating that its patented gait technology can create biomarkers to identify and manage neurological conditions. The first-of-its-kind study tested the reliability and accuracy of accelerometer-based gait assessment data. The study found that SportGait’s BKG gait method and algorithms are superior in accuracy and usability for measuring and managing concussion outcomes.

“My core hypothesis is that the way we move through space reflects our overall health status. The BKG can be used as a biomarker of disease because each condition has a characteristic biokinetic signature,” said Dr. Mark Williams, MD and BKG Innovator. “I created the BKG measuring other neurological conditions like Parkinson’s Disease and Stroke, and I suspected that its application for mild traumatic brain injury would be equally as effective.”

In the study, data collected by the accelerometer was used to create BioKinetoGraphs (BKG^TM), which are a visual depiction of a person’s gait. Like the shape of an EKG waveform, the graph-like displays visually correspond to different events during a gait cycle such as the heal striking the ground or the toe pushing off of it.  

“Physical, and in this case gait, biomarkers are becoming a critical component for healthcare,” commented SportGait President and CEO Chris Newton. “Our team has worked tirelessly to create reliable and valid assessments and when you start looking at concussion, gait and balance are critical to measure. Our goal is to provide invaluable patient data to doctors who can use this information to improve care and, ultimately, health outcomes.”

The research article was published in the Journal of Concussion in February 2023, and appears in Volume 7: 1-11. Link to peer reviewed paper The lead author and head of the multifacility research consortium, Dr. Len Lecci, Ph.D. said, “What our research has shown is that the data derived from one’s gait are unique and effectively complement neurocognitive assessments to provide a more comprehensive evaluation of the possible consequences of a concussion.”

The peer-reviewed paper, in part, compares predicting concussion symptom endorsements, and the SportGait BKG predicts with effect sizes 4.4 times larger than the popular Balance Error Scoring System (BESS), 2.9 times larger than the National Institute of Health’s 4-M Gait Test, and 1.7 times larger than the two combined. 

“It is exciting to see that a simple twenty (20)-step walking test can outperform the time-consuming disparate balance and gait assessments,” Newton continued. “Dr. Mark is a visionary and well ahead of his time. Athletes and patients will benefit greatly from his invention.”

SportGait, which offers a scalable platform for medical providers, sports organizations, coaches and parents, seeks to bridge the gap between brain wellness and medical technology using a best-in-class, research-backed application developed by a team of doctors and scientists focused on the field of concussion.

About SportGait

SportGait is a concussion support and recovery system that offers a scalable platform for medical providers, coaches, and parents. Their array of assessments are best-in-class and research-backed with the goal of bridging brain wellness with medical technology. The scientifically developed system aids and educates users in effectively evaluating and monitoring concussions. SportGait is a highly trusted source of medical technology, and was chosen to be the enterprise-wide standard for concussion testing for one of the top five largest hospital systems in the U.S. For more information please visit https://sportgait.com.

Contact Information:

Bethany Vietmeier

Marketing Manager

[email protected]

4127205195

Original Source:

SPORTGAIT’S BKG PATENTED GAIT TECHNOLOGY PREDICTIVE CAPABILITIES VETTED AND PUBLISHED

The industry’s leader in ADHD assessment and treatment said telehealth will return to pre-pandemic rules when the Public Health Emergency expires on May 11.

GRAND RAPIDS, Mich., February 23, 2023 (Newswire.com)
–
ADHD Online, the leader in online ADHD assessment and treatment options, said patients using telehealth for access to certain prescriptions must take specific steps to prepare for changes related to the end of the national Public Health Emergency (PHE) on May 11. 

“The pending end of the Public Health Emergency will change how telemedicine and telehealth operate,” said ADHD Online co-founder and CEO Zachariah Booker. “It is vital that patients who utilize telehealth and telemedicine are aware of how this will impact them moving forward with treatment plans and prescriptions.” 

The Department of Health and Human Services announced Feb. 9 that the PHE implemented in response to the COVID-19 pandemic will expire on May 11.

In order to speed vaccine development and to help people maintain access to their doctors and medications, the PHE temporarily suspended many healthcare regulations. Among them was a requirement that physicians, with limited exceptions, must conduct an in-person medical examination of a patient in order to prescribe a controlled substance.

The PHE allowed telemedicine companies like ADHD Online to prescribe all types of medication without an in-person exam, a vital option during the pandemic when patients were often unable to see their doctors in person and telehealth became a primary way of receiving healthcare. 

As of May 11, pre-pandemic rules will apply and telemedicine companies will not be able to prescribe controlled substances without an in-person exam. This includes any medication prescribed to those with ADHD. Patients who want to continue to use telehealth to receive prescriptions for medications on the federally controlled substance lists must be able to document that they have seen a physician within the past two years. 

ADHD Online is recommending that its patients taking widely used medications like Adderall, Ritalin and Concerta (or any other medications on this list) take the following steps:  

If they have seen a doctor in the past 23 months, they should send this form to the healthcare provider and ask the provider to complete the form. Then the provider or patient should return the form to ADHD Online.

If they have not seen a doctor over the past 23 months, they should schedule an in-person physical with their primary care provider and bring this form to the provider to complete. Then the provider or patient should return the form and a summary of the patient’s doctor visit to ADHD Online.

“Taking these steps will ensure that patients will continue to receive their medications after the expiration of the PHE,” Booker said. “Rest assured that ADHD Online is here for you, and we’re working hard to make sure you will continue to receive care and treatment for your ADHD.”

About ADHD Online
ADHD Online was founded in 2018 with the mission that everyone should have access to quality ADHD assessments regardless of who and where they are. The ADHD Online team is filled with industry experts across the United States who all share the same passion for ADHD and making sure patients have access to critical mental health services. ADHD Online is leading the way with being a critical voice for those who might be struggling with ADHD and is the only organization to offer HIPAA-secured ADHD assessments online with certified results from licensed psychologists. ADHD Online is active in all 50 states.

Contact Information:

Mike Albanese

[email protected]

Original Source:

ADHD Online Alerts People to Changes in Telehealth, Prescriptions as Public Health Emergency Ends

Virtual Scribe market leader and pioneer adds solutions to combat growing clinician burnout epidemic.

AQuity Logo AQuity Logo
…

The Dan Lewis Foundation for Brain Regeneration Research (the DLF) announces the 2023 DLF Prize.

DENVER, February 23, 202…